Dr. Natalia Haraszkiewicz-Birkemeier, a Scientific Advisor to the European Commission with over two decades of experience, plays a pivotal role in shaping EU health policy. Her expertise contributes to the implementation of Health Technology Regulation 2021/2282, the Critical Medicines Act and Biotechnology Act proposals, and the EU’s Startups/Scale-ups Strategy. Furthermore, she supports the implementation of the European Innovation Act, aligning with the Commission’s broader strategy to enhance innovation and competitiveness across the EU.
In the context of healthcare transformation, Dr. Haraszkiewicz-Birkemeier focuses on innovation metrics, strategies for emerging businesses, and the regulatory environment shaping the future of European healthcare. Her approach emphasizes balancing innovation with patient safety while supporting SMEs.

As the Ambassador of the Early Warning Europe Mentor Academy, she provides guidance on entrepreneurship, standards practices, and business resilience to European enterprises. Dr. Haraszkiewicz-Birkemeier’s efforts are characterized by a commitment to improving health outcomes for EU citizens, enhancing quality of care, and strengthening the competitiveness and sustainability of the European healthcare sector.